Effect of Low-Volume HIT vs. MIC Exercise in Individuals With Increased BMI

September 2, 2024 updated by: Riphah International University

Effect of Low-Volume High-Intensity Training vs. Moderate Intensity Continuous Exercise on Rate Pressure Product and Functional Capacity in Individuals With Increased BMI

To compare the effect of low volume high intensity training and moderate intensity continuous exercise on Rate Pressure Product (RPP) and functional capacity. Limited literature available on effectiveness of Low-volume HIIT in comparison of other Aerobic interventions in obese individuals. In our community, people are sedentary and not involved in routine exercise because of increased weight, so Low volume HIIT would be safe and convenient for such individuals to perform. There is also limited studies available on female gender so both genders are included in this study.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Some recent studies suggest that the rising interest for the potential of high- intensity interval training (HIIT) to enhance the metabolic health in overweight adults. HIIT has also been found to induce comparatively fast enhancements in overall-body aerobic capacity and muscle mitochondrial markers in individuals with overweight.

The main advantage of HIIT is that low-volume HIIT protocols can involve a shorter time as compared with MICT, and time limitations have been recognized as a generally reported hurdle to daily exercise involvement.

Latest studies propose that's when compared to moderate intensity continuous training (MICT), HIIT has been shown to produce similar and sometimes better improvements in results such as cardiorespiratory fitness in spite of often demanding a smaller amount of time commitment and lesser energy expenditure. On the other hand, low volume HIIT is still undecided whether this form of physical training is superior, equivalent or inferior to more outdated forms of exercise training such as MICT for the management cardio metabolic health.

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Body mass index 23-29.9 kg/m 2 (Overweight-Type I Obese)
  • Able to do exercise (PAR-Q)

Exclusion Criteria:

  • History of chronic diseases and medication use
  • Considerable mental or physical disability, neurological or musculoskeletal problems
  • Severe personality disorders or drug addiction.
  • Pregnant females

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GROUP A
Low-volume High intensity interval training
Other: Low-volume high intensity interval training

Week 1 & 2:

Warm-up: 10 minutes at 50% THR Work: 1x4 minutes at 80% THR followed by 1*4 minutes Recovery at 50% THR Cool down: 5 minutes at 50% THR Total exercise time: 23 minutes

Week 3 & 4:

Warm-up: 10 minutes at 50% THR Work: 2x6 minutes at 80% THR followed by 1*6 minutes Recovery at 50% THR Cool down: 5 minutes at 50% THR Total exercise time: 33 minutes
Experimental: GROUP B
Moderate intensity continous exercise
Other: Moderate intensity continuous exercise

Week 1 & 2:

Warm-up: 5 minutes at 50% THR Work: 20 minutes at 60% VO 2 THR Cool Down: 5 minutes at 50% THR Total exercise time: 30 minutes

Week 3 & 4:

Warm-up: 5 minutes at 50% THR Work: 30 minutes at 60% THR Cool Down: 5 minutes at 50% THR Total exercise time: 40 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate Pressure Product
Time Frame: 2 weeks, 4 weeks
Changes from baseline to 2 weeks and 4 weeks after the intervention, measured through product of heart rate and systolic blood pressure, is a very reliable indicator of myocardial oxygen demand. An RPP above 20,000 mmHg per minute is considered healthy, whereas anything below 16,000 mmHg is considered insufficient.
2 weeks, 4 weeks
Functional Capacity
Time Frame: 2 Weeks, 4 Weeks
Changes from baseline to 2 weeks and 4 weeks after the intervention, measured through 6 min walk test (6 MWT). It is a submaximal exercise test that can aid in assessing the functional/exercise capacity of patients with cardiopulmonary diseases, in this test we find out the maximum distance in meters that an individual covers in 6 min without any support.
2 Weeks, 4 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Mehwish Waseem, MSPT-CPPT, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2024

Primary Completion (Estimated)

September 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

September 2, 2024

First Submitted That Met QC Criteria

September 2, 2024

First Posted (Estimated)

September 5, 2024

Study Record Updates

Last Update Posted (Estimated)

September 5, 2024

Last Update Submitted That Met QC Criteria

September 2, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Rec/01817 Asma Rehman

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Low-volume high intensity interval training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe